EN, página actualES
Subscribe, it's free

TechWearables

FDA clears MiniMed Fit, MiniMed's first tubeless pump

MiniMed says the patch pump wears up to seven days and holds 300 units of insulin. A phased US rollout starts in spring 2027, and the clearance brings a $162 million charge.

Grant Whitaker · 2 min read
A MiniMed Paradigm insulin pump with the MiniMed name on its screen, connected by clear tubing to an infusion set and its blue inserter
Photo: David-i98 / Public domain, via Wikimedia Commons (Public domain)

MiniMed Fit, MiniMed’s first tubeless insulin pump, has FDA clearance, the company said in a Nov. 16 release. The patch pump can be worn for up to seven days and holds 300 units of insulin. It is cleared for people with Type 1 and Type 2 diabetes ages 7 and older.

MiniMed is the diabetes device business that separated from Medtronic earlier this year, MedTech Dive reported. Until now its pumps used tubing. The Fit sticks to the body and is controlled from a phone.

What the device does

MiniMed Fit runs SmartGuard, MiniMed’s automated insulin delivery software. It adjusts insulin delivery on its own and can give correction doses every five minutes. A Meal Detection feature can add insulin when a meal dose is missed or too small. People control the pump through an app on compatible iPhone and Android phones.

At launch, users can pair the pump with one of two sensors. MiniMed’s Simplera Sync is worn for up to seven days. Instinct, made by Abbott, is worn for up to 15 days. The pump is waterproof and works with Humalog, NovoLog and Admelog insulin. MiniMed said seven days of wear applies to people who use less than 42 units of insulin a day.

The launch

The FDA cleared the pump several months earlier than MiniMed expected, the company said in an 8-K filing. MiniMed submitted it for review in late August, Drug Delivery Business reported.

MiniMed now plans a phased US rollout starting in spring 2027. It had previously said summer 2027. An early customer experience phase comes first, in MiniMed’s fiscal fourth quarter of 2027. The company said it plans to significantly expand manufacturing capacity.

MiniMed Fit will be sold through pharmacies. “Clearing FDA ahead of schedule is more proof we’re executing our strategy,” said Que Dallara, MiniMed’s chief executive. “It puts MiniMed Fit in U.S. customers’ hands sooner, and the pharmacy channel makes it easier to get.”

The charge

The clearance triggers a one-time charge of $162 million in MiniMed’s fiscal 2027 third quarter, the 8-K said. The money is a minimum payment due for the first two years after US approval and launch of the pump. It comes from a research and development agreement with affiliates of Blackstone Life Sciences Advisors. MiniMed took on that obligation when it separated from Medtronic.

MiniMed will not exclude the charge from adjusted EBITDA. Third quarter and full year fiscal 2027 EBITDA and adjusted EBITDA will each be $162 million lower as a result. The cash is paid over time, based on product sales and other terms of the agreement. MiniMed said the charge does not change its outlook for the business.

The market

Insulet is the market leader in tubeless insulin pumps, MedTech Dive reported. Tandem Diabetes Care has just launched its first tubeless pump. MiniMed Fit will enter that market when the rollout begins next spring.

$162 million
The NumberOne-time charge MiniMed expects in its fiscal 2027 third quarter now that MiniMed Fit is clearedA minimum payment under a research and development deal with affiliates of Blackstone Life Sciences that MiniMed took on when it separated from Medtronic (MiniMed Form 8-K, Nov. 16, 2026). Source: MiniMed, FDA Clears MiniMed Fit, release via PR Newswire, Nov. 16, 2026
Sources
  1. MiniMed, FDA Clears MiniMed Fit, release via PR Newswire, Nov. 16, 2026 (prnewswire.com)
  2. MiniMed Group, Inc., Form 8-K, Item 7.01, Nov. 16, 2026 (sec.gov)
  3. MedTech Dive, MiniMed gets FDA nod for tubeless insulin pump, Nov. 16, 2026 (medtechdive.com)
  4. Drug Delivery Business, MiniMed claims quick FDA clearance for Fit patch pump, Nov. 16, 2026 (drugdeliverybusiness.com)
More TechMore Wearables
Health and Tech Now is an independent publication. Views are not those of any employer. Public sources only.